Article Details

AstraZeneca to buy US-based CinCor Pharma for $1.8bn - Pharmaceutical Technology

Retrieved on: 2023-01-10 08:35:04

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to buy US-based CinCor Pharma for $1.8bn - Pharmaceutical Technology. View article details on hiswai:

Excerpt

AstraZeneca has signed a definitive agreement to buy US-based biopharmaceutical company CinCor Pharma in a deal valued at about $1.8bn.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up